Cited 22 times in
Potential use of glioblastoma tumorsphere: clinical credentialing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강석구 | - |
dc.contributor.author | 김선호 | - |
dc.contributor.author | 김의현 | - |
dc.contributor.author | 장종희 | - |
dc.contributor.author | 정재호 | - |
dc.contributor.author | 허용민 | - |
dc.date.accessioned | 2016-02-04T11:01:57Z | - |
dc.date.available | 2016-02-04T11:01:57Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/139512 | - |
dc.description.abstract | A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 402~407 | - |
dc.relation.isPartOf | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Biomedical Research/methods* | - |
dc.subject.MESH | Glioblastoma/pathology* | - |
dc.subject.MESH | Glioblastoma/therapy | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Molecular Targeted Therapy | - |
dc.subject.MESH | Neoplastic Stem Cells/metabolism* | - |
dc.title | Potential use of glioblastoma tumorsphere: clinical credentialing | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurosurgery (신경외과학) | - |
dc.contributor.googleauthor | Seok-Gu Kang | - |
dc.contributor.googleauthor | Jae-Ho Cheong | - |
dc.contributor.googleauthor | Yong Min Huh | - |
dc.contributor.googleauthor | Eui Hyun Kim | - |
dc.contributor.googleauthor | Sun Ho Kim | - |
dc.contributor.googleauthor | Jong Hee Chang | - |
dc.identifier.doi | 10.1007/s12272-015-0564-0 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00036 | - |
dc.contributor.localId | A00560 | - |
dc.contributor.localId | A00837 | - |
dc.contributor.localId | A03470 | - |
dc.contributor.localId | A03717 | - |
dc.contributor.localId | A04359 | - |
dc.relation.journalcode | J00229 | - |
dc.identifier.pmid | 25628248 | - |
dc.identifier.url | http://link.springer.com/article/10.1007%2Fs12272-015-0564-0 | - |
dc.subject.keyword | Cancer stem cell | - |
dc.subject.keyword | Clinical credentialing | - |
dc.subject.keyword | Glioblastoma | - |
dc.subject.keyword | Intratumoral heterogeneity | - |
dc.subject.keyword | Testing platform | - |
dc.subject.keyword | Tumorsphere | - |
dc.contributor.alternativeName | Kang, Seok Gu | - |
dc.contributor.alternativeName | Kim, Sun Ho | - |
dc.contributor.alternativeName | Kim, Eui Hyun | - |
dc.contributor.alternativeName | Chang, Jong Hee | - |
dc.contributor.alternativeName | Cheong, Jae Ho | - |
dc.contributor.alternativeName | Huh, Yong Min | - |
dc.contributor.affiliatedAuthor | Kang, Seok Gu | - |
dc.contributor.affiliatedAuthor | Kim, Sun Ho | - |
dc.contributor.affiliatedAuthor | Kim, Eui Hyun | - |
dc.contributor.affiliatedAuthor | Chang, Jong Hee | - |
dc.contributor.affiliatedAuthor | Cheong, Jae Ho | - |
dc.contributor.affiliatedAuthor | Huh, Yong Min | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 38 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 402 | - |
dc.citation.endPage | 407 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, Vol.38(3) : 402-407, 2015 | - |
dc.identifier.rimsid | 55442 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.